Equillium (EQ) Change in Account Payables (2018 - 2026)
Equillium's (EQ) quarterly Change in Account Payables came in at $434000.0 in Q1 2026, up 13.91% year-on-year from $381000.0 in Q1 2025, and up 1415.15% on a QoQ basis from -$33000.0 in Q4 2025.
Equillium (EQ) Change in Account Payables (2018 - 2026) Analysis & Trends
Equillium (EQ) has 9 years of Change in Account Payables data on file, last reported at $434000.0 in Q1 2026.
- On a quarterly basis, Change in Account Payables rose 13.91% year-over-year to $434000.0 in Q1 2026; TTM through Mar 2026 was -$1.9 million, a 646.09% decrease from a year earlier, with the FY2025 full-year figure at -$1.9 million, up 2.91% from the prior year.
- Change in Account Payables for Q1 2026 stood at $434000.0, up from -$33000.0 in the prior quarter.
- Over the last five years, Change in Account Payables for EQ reached as high as $2.7 million in Q1 2022 and fell as low as -$4.0 million in Q3 2025.
- Historically, Change in Account Payables has averaged -$15705.9 across 5 years, with a median of $434000.0 in 2026.
- On a YoY basis, Change in Account Payables climbed as much as 650.51% in 2022 and fell as far as 401.38% in 2022.
- Year by year, Change in Account Payables stood at $1.5 million in 2022, then slumped by 30.17% to $1.0 million in 2023, then slumped by 190.73% to -$949000.0 in 2024, then surged by 96.52% to -$33000.0 in 2025, then soared by 1415.15% to $434000.0 in 2026.
- Per Business Quant data, the three most recent Change in Account Payables figures were $434000.0 in Q1 2026, -$33000.0 in Q4 2025, and -$4.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | -42.19 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 16.86 Mn |
| 10 | Equillium | 242.14 Mn | 242.14 Mn | - | 434,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 434,000.00 |
| Mar 31, 2026 | 434,000.00 |
| Dec 31, 2025 | -33,000.00 |
| Dec 31, 2025 | -33,000.00 |
| Sep 30, 2025 | -4.03 Mn |
| Sep 30, 2025 | -4.03 Mn |
| Jun 30, 2025 | 1.75 Mn |
| Jun 30, 2025 | 1.75 Mn |
| Mar 31, 2025 | 381,000.00 |
| Mar 31, 2025 | 381,000.00 |
| Dec 31, 2024 | -949,000.00 |
| Dec 31, 2024 | -949,000.00 |
| Sep 30, 2024 | -843,000.00 |
| Sep 30, 2024 | -843,000.00 |
| Jun 30, 2024 | 1.76 Mn |
| Jun 30, 2024 | 1.76 Mn |
| Mar 31, 2024 | -1.96 Mn |
| Mar 31, 2024 | -1.96 Mn |
| Dec 31, 2023 | 1.05 Mn |
| Dec 31, 2023 | 1.05 Mn |